Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis

Allergol Int. 2022 Apr;71(2):259-261. doi: 10.1016/j.alit.2021.11.003. Epub 2022 Jan 21.

Affiliations

¹ Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
² Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: chieko-m@ceres.ocn.ne.jp.
³ Department of Diagnostic Pathology, Kumamoto University, Kumamoto, Japan.

PMID: 35074267
DOI: 10.1016/j.alit.2021.11.003

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Churg-Strauss Syndrome* / diagnosis
Churg-Strauss Syndrome* / drug therapy
Granulomatosis with Polyangiitis* / diagnosis
Granulomatosis with Polyangiitis* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
dupilumab
mepolizumab